Navigation Links
FDA: Possible Fracture Risk With High Dose, Long-term Use of Proton Pump Inhibitors
Date:5/25/2010

and, when prescribing proton pump inhibitors, health care professionals should consider whether a lower dose or shorter duration of therapy would adequately treat the patient's condition."

FDA's warning and decision to revise the labeling of proton pump inhibitors are based on the Agency's review of several epidemiological studies that reported an increased risk of fractures of the hip, wrist and spine in patients using proton pump inhibitors. Both the Warnings and Precautions section of the prescription labeling and the Drug Facts label on OTC proton pump inhibitors will address these findings.

Health care professionals and consumers should weigh the known benefits against the potential risks of proton pump inhibitors when determining if these medications are appropriate for treatment. Consumers also should talk with their health care professional about any concerns.

Any side effects or other product problems with proton pump inhibitors should be reported to FDA's MedWatch Adverse Event Reporting program at www.fda.gov/MedWatch or by calling 800-332-1088.

For more information

Drug Safety Communication

http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm213206.htm

Media Inq
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival
2. Independent Studies Report on Possible Roles for Cylexs Immune Cell Function Assay in Monitoring of Heart and Lung Transplant Recipients
3. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
4. Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients
5. Pediatric Researchers Find Possible Master Switch Gene in Juvenile Arthritis
6. Study Suggests a Possible Way to Offset Chemobrain Memory Loss
7. New Study Shows Cloning from Dried Cells Now Possible
8. Kroger Recalls Peanut Butter Bakery Cookies and Select Cakes Due to Possible Health Risk
9. The Childrens Hospital of Philadelphia: New Gene-Searching Method Uncovers Possible New Targets for Crohns Disease Drugs
10. New Reconstruction Method Makes Speaking, Eating Possible After Tonsil Cancer Surgery, U-M Study Shows
11. FDA: Byetta Label Revised to Include Safety Information on Possible Kidney Problems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... STAMFORD, Conn. , Aug. 31, 2015 ... Co., Ltd., and Purdue Pharma L.P. announced today that ... the development and commercialization of Eisai,s clinical candidate lemborexant ... Phase III clinical development for the treatment of insomnia. ... Eisai and Purdue Pharma will share the costs of ...
(Date:8/31/2015)... Wash. , Aug. 31, 2015   ... the leading developer, manufacturer and marketer of proprietary ... and cryopreservation freeze media and ... management app for smart shippers ... customer TiGenix NV, an advanced biopharmaceutical company focused ...
(Date:8/30/2015)... ANDOVER, Massachusetts y LONDRES, August 30, 2015 ... conectada ofrece una visión holística de l ... de todo el trayecto   ... anunciado hoy el debut europeo de IntelliSpace Cardiovascular ... información que ofrece sofisticadas herramientas para acceder, analizar y ...
Breaking Medicine Technology:Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 2BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 3BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 4BioLife Solutions Customer TiGenix Phase 3 Clinical Trial Meets Primary Endpoint 5Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3
... , NEW YORK, ... research report is available in its catalogue: , ... , http://www.reportlinker.com/p0167105/US-Home-Healthcare-Equipment--Services-Market-An-Analysis.html , Home healthcare equipment ... important part of the healthcare industry over the years. ...
... , ... that a new market research report is available in ... Trays - A World Market Analysis , ... infection control requirements constitute key growth drivers for prepackaged ...
Cached Medicine Technology:Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 2Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 3Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 4Reportlinker Adds US Home Healthcare Equipment & Services Market: An Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 2Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 3Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 4Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 5Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 6Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 7Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 8Reportlinker Adds Prepackaged Medical Kits and Trays - A World Market Analysis 9
(Date:8/31/2015)... ... August 31, 2015 , ... Diablo Publications ... that it has officially launched a new website and company identity ( diablopublications.com) ... are more closely aligned with the company’s strategic vision for growth and expansion ...
(Date:8/31/2015)... ... August 31, 2015 , ... Three Bakers Gluten Free Bakery launched the ... more relevant and easy-to-find information on their offering of gluten-free breads and pizzas, living ... an important way for us to share information about our gluten free product offerings, ...
(Date:8/31/2015)... ... , ... Finnleo , a leader in the sauna industry, is pleased ... the newly re-styled and re-designed “Hallmark Series” updates the Passport series with a feature ... more glass and a more upscale feel than the current Passport a beautiful 6-bar ...
(Date:8/31/2015)... ... August 31, 2015 , ... American Family Care (AFC), the ... existing presence in Tennessee with the opening of a new urgent care facility ... Knoxville, sixteenth in Tennessee, and 148th in the U.S. overall. , “We’re excited ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... may be at a greater risk for injury, potentially because they are more ... of Pittsburgh Graduate School of Public Health analysis discovered. , The research, ...
Breaking Medicine News(10 mins):Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2Health News:Finnleo Introduces Hallmark Series Saunas 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3
... Safety for Patients, Adds Convenience Through Easy-to-Read Labeling, Standardized ... BETHLEHEM, Pa.Dec. 3, Central Admixture Pharmacy Services Inc. ... announced today that it will introduce a number of ... labeling, extended Beyond-Use-Dating (BUD) and American Society for Testing ...
... Bally Total Fitness Corporation ("Bally"),today announced that it ... chapter 11 petition was filed today in the U.S. ... Bally intends to use the chapter,11 process to significantly ... its core operations. It expects to accomplish,these goals ...
... 3, 2008 Joined by actress Maggie,Gyllenhaal, Duracell(R) today announced the ... in age from six to 15 years old --,at an event ... best known for her role in "The Dark Knight," to promote ... of powering,up a gift for the first time to those most ...
... in the wound, researchers say , , WEDNESDAY, Dec. ... people wound themselves and then place objects in ... teens, especially girls, researchers say. , Slated to ... of North America,s annual meeting in Chicago, doctors ...
... MDIn addition to its strong associations with hypertension, ... alterations in thyroid function and structure, according to ... Endocrine Society,s Journal of Clinical Endocrinology & ... drive metabolism, however demonstration of a direct or ...
... www.bodyinsight101.com ), a company devoted to injury prevention through exercise, has created ... The Strong Knees DVD, hosted by physical therapist Chantal Donnelly, is ... of this Knee Pain Relief DVD is perfect for the gift giving ... ...
Cached Medicine News:Health News:Writing a Prescription for Safety: B. Braun CAPS(R) Announces New Advancements at ashp 2008 2Health News:Writing a Prescription for Safety: B. Braun CAPS(R) Announces New Advancements at ashp 2008 3Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 2Health News:Bally Total Fitness Files for Chapter 11 Bankruptcy Protection 3Health News:Duracell and Actress Maggie Gyllenhaal Announce Winners of 'Power A Smile' Casting Call After Nationwide Search for Five Child Holiday Ambassadors 2Health News:Duracell and Actress Maggie Gyllenhaal Announce Winners of 'Power A Smile' Casting Call After Nationwide Search for Five Child Holiday Ambassadors 3Health News:'Self-Embedding' a Troubling Trend Among Teens 2Health News:Pediatric obesity may alter thyroid function and structure 2Health News:New Strong Knees DVD Offers Knee Pain Relief from Body Insight, Inc. and Gaiam Inc. 2
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs....
Permanent, sutureless, epicardial pacing leads...
Bipolar Ventricular Lead...
Medicine Products: